Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. RNAZ fell sharply during Friday’s session.

TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.

TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Charge Enterprises, Inc. CRGE shares surged 105.4% to $0.2510.
  • Kaman Corporation KAMN shares climbed 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.
  • Mesa Air Group Inc MESA gained 70.4% to $1.09 as the company entered into new agreements with United Airlines for improved operating and financing terms.
  • Edgewise Therapeutics, Inc. EWTX rose 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.
  • Processa Pharmaceuticals, Inc. PCSA climbed 34.2% to $0.2725. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer.
  • Tricon Residential Inc. TCN shares gained 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.
  • Spirit Airlines, Inc. SAVE jumped 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue "remains in full force and effect."
  • Super Micro Computer, Inc. SMCI climbed 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.
  • Allied Gaming & Entertainment Inc. AGAE rose 20.6% to $1.1190.
  • Portage Biotech Inc. PRTG gained 19% to $1.14.
  • ProMIS Neurosciences, Inc. PMN gained 19% to $2.07.
  • Shuttle Pharmaceuticals Holdings, Inc. SHPH gained 16.4% to $0.5185.
  • Treasure Global Inc. TGL shares rose 14.2% to $0.1176. Treasure Global and AIO Synergy recently entered into a strategic alliance aimed at reshaping the landscape of artificial intelligence.
  • Silk Road Medical, Inc SILK jumped 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.
  • Wayfair Inc. W jumped 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.
  • Bullfrog AI Holdings, Inc. BFRG gained 10.6% to $4.30.
  • NewAmsterdam Pharma Company N.V. NAMS rose 10.5% to $19.44.
  • World Acceptance Corporation WRLD gained 10.2% to $134.00 following upbeat quarterly results.
  • Ally Financial Inc. ALLY gained 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial's point of sale financing business. Ally Financial also posted upbeat quarterly sales.
  • Cyngn Inc. CYN surged 8.8% to $0.1468 after gaining over 5% on Thursday.
  • Mesoblast Limited MESO gained 8.1% to $1.86 after the FDA granted a Rare Pediatric Disease Designation to the company’s Revascor® for treating children with congenital heart disease.
  • WNS (Holdings) Limited WNS rose 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.

Losers

  • C3is Inc. CISS shares fell 63.2% to $0.1384 as the company announced pricing of $7.0 million upsized underwritten public offering.
  • Azitra, Inc. AZTR dipped 31.8% to $1.3976 after the company filed for a firm commitment public offering of 3 million shares of common stock.
  • iRobot Corporation IRBT fell 30% to $16.53 following a report suggesting the EU plans to block Amazon's acquisition of the company.
  • Accelerate Diagnostics, Inc. AXDX fell 27.1% to $1.17 after the company reported pricing of approximately $15 million public offering and private placement.
  • AST SpaceMobile, Inc. ASTS declined 24.3% to $3.15. AST SpaceMobile announced a $100 million offering of common stock. The company also announced a strategic investment from AT&T Inc T,
  • Alphabet Inc GOOG GOOGL and Vodafone.
  • Agrify Corporation AGFY dipped 21.9% to $1.0699. Agrify entered into a multi-million dollar sales agreement with Ocean Deep/Golden Lake Business Park.
  • Adagene Inc. ADAG fell 21.6% to $2.64.
  • BioCardia, Inc. BCDA fell 20% to $0.46.
  • Volato Group, Inc. SOAR fell 17.2% to $2.1688.
  • Datasea Inc. DTSS shares fell 16.4% to $0.1140. Datasea announced plans for a 1-for-15 reverse stock split to regain compliance with Nasdaq minimum bid requirement.
  • Orgenesis Inc. ORGS dipped 15.3% to $0.2711.
  • Wheels Up Experience Inc. UP fell 12.6% to $3.19.
  • Nkarta, Inc. NKTX fell 12.2% to $7.47.
  • Vision Marine Technologies Inc. VMAR shares fell 11.5% to $0.7098. Vision Marine Technologies announced close of $3.0 million private placement of convertible preferred shares and warrants with Investissement Québec.
  • Absci Corporation ABSI dipped 11.3% to $3.2120.
  • Lithium Americas Corp. LAC fell 10.4% to $4.3650.
  • Celsius Holdings, Inc. CELH fell 10% to $53.60 after B of A Securities downgraded the stock from Buy to Neutral and announced a $65 price target.
  • Hut 8 Corp. HUT dipped 9.4% to $6.45.
  • Lifezone Metals Limited LZM fell 9.3% to $6.37.
  • MorphoSys AG MOR fell 7.3% to $9.49 after falling 6% on Wednesday. Morgan Stanley analyst James Quigley, on Tuesday, downgraded MorphoSys from Overweight to Equal-Weight.
  • Hertz Global Holdings, Inc. HTZ declined 6.6% to $8.40 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $12 to $8.
  • Esperion Therapeutics, Inc. ESPR shares fell 6.1% to $2.0188. Esperion priced its $85.1 million public offering of 56.7 million common share at $1.50 per share.
  • Chegg, Inc. CHGG shares fell 6.1% to $9.45. Goldman Sachs analyst Eric Sheridan downgraded Chegg from Neutral to Sell and lowered the price target from $10 to $8.

 

Now Read This: Jim Cramer Predicts A 'Terrific Year' For This Manufacturer, And As For U-Haul? 'I'm Fine With It'

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...